CXCR3 and hepatocellular carcinoma: These data were confirmed in both a xenograft and a fully immuno-competent model of hepatocellular carcinoma, in which DPP4 inhibition also impaired tumor growth by enhancing the CXCR3-mediated NK and T cell infiltration [141].